(Q33813806)

29 July 2017

Systematic review of celecoxib for osteoarthritis and rheumatoid arthritis. Problems compromise review's validity (English)

1 reference

29 July 2017

1 reference

1 reference

1 reference

1

Peter Juni

1 reference

29 July 2017

3

Paul Dieppe

1 reference

29 July 2017

2

Rebekka Sterchi

1 reference

PubMed ID

12574052

29 July 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

29 July 2017

1 reference

29 July 2017

326

1 reference

29 July 2017

334; author reply 334

1 reference

29 July 2017

7384

1 reference

Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1125191

Efficacy and safety of COX 2 inhibitors

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1125191

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1125191

Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1125191

30 October 2018

Identifiers

DOI

10.1136/BMJ.326.7384.334

1 reference

29 July 2017

1 reference

29 July 2017

1 reference